🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective of the low-dose transplant regimen must produce the following eff...
Status
Completed
Location
U.T.M.D. Anderson Cancer Center
Start Date
2001-06
Trial ID
NCT00038844
Treatments Being Tested
This is a standard of care treatment guideline for allogeneic hematopoetic ...
Status
Active Not Recruiting
Location
Masonic Cancer Center, University of Minnesota
Start Date
2012-09-04
Trial ID
NCT01652092
This study uses transplantation to treat patients with problems in their im...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-01-19
Trial ID
NCT00426517
The purpose of this study is to check the T and B cells of the immune syste...
Status
Terminated
Location
Northwestern Memorial Hospital
Start Date
2006-02
Trial ID
NCT01213329
Treatments Being Tested
The purpose of this study is to determine whether Campath-1H induction and ...
Status
Terminated
Location
University of Wisconsin Hospital and Clinics
Start Date
2004-06
Trial ID
NCT00167661
Treatments Being Tested
This study will compare the health and well being of children treated with ...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2001-08
Trial ID
NCT00023192
Treatments Being Tested
This study will investigate the safety and effectiveness of a modified stem...
Status
Completed
Location
National Institute of Allergy and Infectious Diseases (NIAID)
Start Date
2002-02
Trial ID
NCT00031005
Treatments Being Tested
The CD52 antigen, which is targeted by alemtuzumab, is highly expressed on ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-07
Trial ID
NCT00495755
Treatments Being Tested
Hematopoietic stem cell transplantation has proven effective therapy for in...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2006-09
Trial ID
NCT00383448